| This rare crypto pattern was last seen 8 years ago (ad) |
What we're seeing is a rare Bitcoin phenomenon that was last seen eight years ago…
To put things into perspective for you, the last time a cross pattern like this showed up on its chart…
Bitcoin shot up 8,000%...
Now, for the first time in about 8 years, we're about to see this phenomenon repeat itself on Bitcoin this year…
Now I'm not sure whether or not Bitcoin will hit another all-time high like the last time…
But from where we stand right now, I'm very bullish about where we're headed…
And that's because rare patterns like this are what puts more steps on the gas for this new way of crypto trading
This is your best chance at it. |
|
| Free Stock Analysis Report: What's Your Stock Really Worth? (ad) |
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free |
|
 Apple Inc. (AAPL)    Amazon.com, Inc. (AMZN)   Barker Minerals Ltd (BML) - No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today
 Meta Platforms, Inc. (META)   Microsoft Co. (MSFT)  - Alaska Air Group (NYSE:ALK) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $51.00 price target on the stock, up previously from $44.00. This represents a 30.7% upside from the current price of $39.02.
- ASML (NASDAQ:ASML) was upgraded by analysts at Redburn Atlantic from a "sell" rating to a "neutral" rating.The current price is $906.54.
- AvalonBay Communities (NYSE:AVB) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $204.00 price target on the stock, up previously from $194.00. This represents a 15.2% upside from the current price of $177.15.
- Ball (NYSE:BALL) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $74.00 price target on the stock, up previously from $61.00. This represents a 18.8% upside from the current price of $62.31.
- Banco Bradesco (NYSE:BBD) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $2.80 price target on the stock. This represents a 1.1% downside from the current price of $2.83.
- Brunswick (NYSE:BC) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $108.00 price target on the stock, up previously from $100.00. This represents a 23.8% upside from the current price of $87.24.
- Canadian Imperial Bank of Commerce (NYSE:CM) (TSE:CM) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating.The current price is $46.38.
- Dada Nexus (NASDAQ:DADA) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to a "buy" rating. They now have a $3.50 price target on the stock. This represents a 68.3% upside from the current price of $2.08.
- DT Midstream (NYSE:DTM) was upgraded by analysts at Wolfe Research from an "underperform" rating to a "peer perform" rating.The current price is $55.85.
- Equinor ASA (NYSE:EQNR) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $28.50 price target on the stock, up previously from $26.40. This represents a 13.6% upside from the current price of $25.09.
- Freshworks (NASDAQ:FRSH) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $27.00 price target on the stock. This represents a 31.1% upside from the current price of $20.59.
- JetBlue Airways (NASDAQ:JBLU) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock, up previously from $4.00. This represents a 27.7% upside from the current price of $7.05.
- LivaNova (NASDAQ:LIVN) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $70.00 price target on the stock, up previously from $60.00. This represents a 35.6% upside from the current price of $51.61.
- Southwest Airlines (NYSE:LUV) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $42.00 price target on the stock, up previously from $28.00. This represents a 21.8% upside from the current price of $34.49.
- Southwest Airlines (NYSE:LUV) was upgraded by analysts at Sanford C. Bernstein from an "underperform" rating to a "market perform" rating. They now have a $32.00 price target on the stock, up previously from $26.00. This represents a 7.2% downside from the current price of $34.49.
- US Foods (NYSE:USFD) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $59.00 price target on the stock, up previously from $45.00. This represents a 17.3% upside from the current price of $50.31.
- US Foods (NYSE:USFD) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $64.00 price target on the stock, up previously from $47.00. This represents a 27.2% upside from the current price of $50.31.
- View today's most recent analysts' upgrades at MarketBeat.com
| It's Called "the Singularity" (ad) |
A new indicator shows “the Singularity” could launch as soon as three months from now. This is the moment we’ve all feared – when artificial intelligence officially surpasses us… becoming smarter than human intelligence. And when the Singularity hits, the entire world will be thrown into chaos.
Click here to learn how to prepare yourself for what's to come |
|
- American International Group (NYSE:AIG) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $77.00 price target on the stock, up previously from $75.00. This represents a 11.8% upside from the current price of $68.86.
- Alkermes (NASDAQ:ALKS) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating. They now have a $25.00 price target on the stock. This represents a 18.8% downside from the current price of $30.77.
- Couchbase (NASDAQ:BASE) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $29.00 price target on the stock, up previously from $26.00. This represents a 7.2% upside from the current price of $27.04.
- BorgWarner (NYSE:BWA) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating. They now have a $35.00 price target on the stock, down previously from $43.00. This represents a 16.2% upside from the current price of $30.13.
- Caterpillar (NYSE:CAT) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "in-line" rating. They now have a $338.00 price target on the stock, up previously from $321.00. This represents a 7.1% upside from the current price of $315.50.
- Camden Property Trust (NYSE:CPT) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $100.00 price target on the stock, down previously from $138.00. This represents a 5.4% upside from the current price of $94.90.
- Granite Point Mortgage Trust (NYSE:GPMT) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.The current price is $4.54.
- W.W. Grainger (NYSE:GWW) was downgraded by analysts at Loop Capital from a "buy" rating to a "hold" rating. They now have a $1,000.00 price target on the stock, up previously from $925.00. This represents a 6.8% upside from the current price of $936.48.
- Holley (NYSE:HLLY) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $5.00 price target on the stock, down previously from $6.50. This represents a 13.1% upside from the current price of $4.42.
- Hudson Pacific Properties (NYSE:HPP) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating. They now have a $7.50 price target on the stock, down previously from $11.00. This represents a 8.2% upside from the current price of $6.93.
- Healthcare Realty Trust (NYSE:HR) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating. They now have a $15.00 price target on the stock, down previously from $19.00. This represents a 7.6% upside from the current price of $13.94.
- Healthcare Realty Trust (NYSE:HR) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $15.00 price target on the stock, down previously from $19.00. This represents a 7.6% upside from the current price of $13.94.
- Ingersoll Rand (NYSE:IR) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "in-line" rating. They now have a $89.00 price target on the stock, up previously from $81.00. This represents a 2.2% upside from the current price of $87.07.
- Johnson Controls International (NYSE:JCI) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.The current price is $56.81.
- MSCI (NYSE:MSCI) was downgraded by analysts at Redburn Atlantic from a "neutral" rating to a "sell" rating. They now have a $470.00 price target on the stock, down previously from $620.00. This represents a 15.5% downside from the current price of $556.44.
- Natera (NASDAQ:NTRA) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $85.00 price target on the stock, up previously from $68.00. This represents a 23.1% upside from the current price of $69.05.
- Prelude Therapeutics (NASDAQ:PRLD) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $5.00 price target on the stock. This represents a 26.6% upside from the current price of $3.95.
- RAPT Therapeutics (NASDAQ:RAPT) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.The current price is $9.54.
- Sunoco (NYSE:SUN) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $62.00 price target on the stock. This represents a 0.4% upside from the current price of $61.77.
- TreeHouse Foods (NYSE:THS) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating. They now have a $35.00 price target on the stock, down previously from $45.00. This represents a 1.0% downside from the current price of $35.34.
- Timken (NYSE:TKR) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "in-line" rating. They now have a $84.00 price target on the stock. This represents a 4.4% upside from the current price of $80.45.
- Texas Roadhouse (NASDAQ:TXRH) was downgraded by analysts at Northcoast Research from a "buy" rating to a "neutral" rating.The current price is $147.19.
- UDR (NYSE:UDR) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $37.00 price target on the stock, down previously from $46.00. This represents a 4.0% upside from the current price of $35.59.
- View today's most recent analysts' downgrades at MarketBeat.com
| Gold is SOARING – here's what you need to do (ad) |
Everything is lining up perfectly for a historic gold bull run. One gold expert says he's found the best way to get in, for just $5.
Click here for full details. |
|
- AGNC Investment (NASDAQ:AGNC) is now covered by analysts at Compass Point. They set a "buy" rating and a $10.25 price target on the stock. This represents a 8.1% upside from the current price of $9.48.
- ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $35.00 price target on the stock. This represents a 65.6% upside from the current price of $21.14.
- ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $30.00 price target on the stock. This represents a 41.9% upside from the current price of $21.14.
- ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $27.00 price target on the stock. This represents a 27.7% upside from the current price of $21.14.
- biote (NASDAQ:BTMD) is now covered by analysts at B. Riley. They set a "buy" rating and a $9.00 price target on the stock. This represents a 85.2% upside from the current price of $4.86.
- BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $11.50 price target on the stock. This represents a 9.5% upside from the current price of $10.50.
- BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $18.00 price target on the stock. This represents a 71.4% upside from the current price of $10.50.
- BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $26.00 price target on the stock. This represents a 147.6% upside from the current price of $10.50.
- BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $15.00 price target on the stock. This represents a 42.9% upside from the current price of $10.50.
- BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $18.00 price target on the stock. This represents a 71.4% upside from the current price of $10.50.
- BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $15.00 price target on the stock. This represents a 42.9% upside from the current price of $10.50.
- BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $14.00 price target on the stock. This represents a 33.3% upside from the current price of $10.50.
- BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $15.00 price target on the stock. This represents a 42.9% upside from the current price of $10.50.
- BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at Guggenheim. They set a "buy" rating and a $15.00 price target on the stock. This represents a 42.9% upside from the current price of $10.50.
- CG Oncology (NASDAQ:CGON) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $75.00 price target on the stock. This represents a 60.0% upside from the current price of $46.87.
- CG Oncology (NASDAQ:CGON) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $55.00 price target on the stock. This represents a 17.3% upside from the current price of $46.87.
- CG Oncology (NASDAQ:CGON) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $42.00 price target on the stock. This represents a 10.4% downside from the current price of $46.87.
- Dyne Therapeutics (NASDAQ:DYN) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $36.00 price target on the stock. This represents a 57.5% upside from the current price of $22.86.
- enGene (NASDAQ:ENGN) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $31.00 price target on the stock. This represents a 102.7% upside from the current price of $15.29.
- Immunovant (NASDAQ:IMVT) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $51.00 price target on the stock. This represents a 33.6% upside from the current price of $38.16.
- Morgan Stanley Direct Lending (NYSE:MSDL) is now covered by analysts at Raymond James. They set an "outperform" rating and a $22.00 price target on the stock. This represents a 7.9% upside from the current price of $20.38.
- Morgan Stanley Direct Lending (NYSE:MSDL) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $23.50 price target on the stock. This represents a 15.3% upside from the current price of $20.38.
- Morgan Stanley Direct Lending (NYSE:MSDL) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $21.00 price target on the stock. This represents a 3.0% upside from the current price of $20.38.
- Morgan Stanley Direct Lending (NYSE:MSDL) is now covered by analysts at Keefe, Bruyette & Woods. They set a "market perform" rating and a $21.00 price target on the stock. This represents a 3.0% upside from the current price of $20.38.
- Morgan Stanley Direct Lending (NYSE:MSDL) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating and a $20.50 price target on the stock. This represents a 0.6% upside from the current price of $20.38.
- Morgan Stanley Direct Lending (NYSE:MSDL) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $21.00 price target on the stock. This represents a 3.0% upside from the current price of $20.38.
- Nuveen Churchill Direct Lending (NYSE:NCDL) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $19.00 price target on the stock. This represents a 7.3% upside from the current price of $17.70.
- Nuveen Churchill Direct Lending (NYSE:NCDL) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $19.00 price target on the stock. This represents a 7.3% upside from the current price of $17.70.
- Nuveen Churchill Direct Lending (NYSE:NCDL) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $18.00 price target on the stock. This represents a 1.7% upside from the current price of $17.70.
- Nuveen Churchill Direct Lending (NYSE:NCDL) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $18.00 price target on the stock. This represents a 1.7% upside from the current price of $17.70.
- Nuveen Churchill Direct Lending (NYSE:NCDL) is now covered by analysts at JMP Securities. They set a "market perform" rating on the stock.The current price is $17.70.
- Nuveen Churchill Direct Lending (NYSE:NCDL) is now covered by analysts at Keefe, Bruyette & Woods. They set a "market perform" rating and a $18.50 price target on the stock. This represents a 4.5% upside from the current price of $17.70.
- View today's most recent analysts' new coverage at MarketBeat.com
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL  |
|
| Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | UPGRADE NOW |
|
View and add up to five holdings to your watchlist.
| VIEW MY PORTFOLIO |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
| JOIN NOW |
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 American Consumer News, LLC dba MarketBeat. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: Elon Musk's "Project Dojo" is a Game-Changer |
|
No comments:
Post a Comment